Orchard Therapeutics plc (ORTX)

Orchard Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	23.47	68.42	55.91	55.14	19.05	335.84
Short-Term Investments	101.94	75.33	164.2	136.81	305.94	0
Cash & Cash Equivalents	125.41	143.75	220.11	191.95	324.99	335.84
Cash Growth	-16.85%	-34.69%	14.67%	-40.94%	-3.23%	273.76%
Receivables	6.19	8.47	1.48	0.88	1.44	2.1
Inventory	6.64	3.4	0	0	0	0
Other Current Assets	15.69	12.53	53.73	30.71	23.46	17.57
Total Current Assets	153.92	168.15	275.32	223.54	349.9	355.52
Property, Plant & Equipment	27.13	30.91	29.08	34.6	27.01	5.48
Long-Term Investments	4.22	4.22	4.27	4.27	4.26	3.84
Goodwill and Intangibles	3.32	3.56	4.15	3.08	0	0
Other Long-Term Assets	13.68	12.08	9.59	15.46	18.11	1.21
Total Long-Term Assets	48.34	50.76	47.09	57.4	49.39	10.53
Total Assets	202.27	218.91	322.41	280.94	399.28	366.04
Accounts Payable	3.66	9.32	10.01	8.82	11.98	18.13
Deferred Revenue	11.09	11.27	12.87	0	0	0
Current Debt	14.98	15.85	8.12	13.8	5.89	0
Other Current Liabilities	19.65	24.12	11.8	28.94	37.98	29.78
Total Current Liabilities	49.38	60.57	42.79	51.56	55.86	47.91
Long-Term Debt	32.84	42.24	51.36	44.37	40.02	0
Other Long-Term Liabilities	39.79	17.84	18.3	6.57	4.21	6.8
Total Long-Term Liabilities	72.63	60.08	69.67	50.94	44.23	6.8
Total Liabilities	122.01	120.64	112.46	102.5	100.09	54.7
Total Debt	47.82	58.09	59.49	58.17	45.91	0
Debt Growth	-18.19%	-2.35%	2.27%	26.70%	-	-
Common Stock	1,024	973.13	956.93	783.7	750.81	598.41
Retained Earnings	-965.92	-900.88	-750.22	-605.64	-453.66	-290.24
Comprehensive Income	22.61	26.02	3.25	0.37	2.04	3.16
Shareholders' Equity	80.26	98.26	209.95	178.43	299.19	311.34
Net Cash / Debt	77.59	85.66	160.62	133.78	279.08	335.84
Net Cash / Debt Growth	-15.99%	-46.67%	20.06%	-52.06%	-16.90%	273.76%
Net Cash Per Share	0.34	0.67	1.30	1.35	2.99	14.89
Working Capital	104.55	107.58	232.53	171.97	294.04	307.61
Book Value Per Share	3.51	7.68	16.94	17.94	32.09	138.01

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).